199 related articles for article (PubMed ID: 32863199)
1. Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019.
Awano N; Inomata M; Kuse N; Tone M; Takada K; Muto Y; Fujimoto K; Akagi Y; Mawatari M; Ueda A; Izumo T
Respir Investig; 2020 Nov; 58(6):440-447. PubMed ID: 32863199
[TBL] [Abstract][Full Text] [Related]
2. Serum KL-6 concentrations as a novel biomarker of severe COVID-19.
d'Alessandro M; Cameli P; Refini RM; Bergantini L; Alonzi V; Lanzarone N; Bennett D; Rana GD; Montagnani F; Scolletta S; Franchi F; Frediani B; Valente S; Mazzei MA; Bonella F; Bargagli E
J Med Virol; 2020 Oct; 92(10):2216-2220. PubMed ID: 32470148
[TBL] [Abstract][Full Text] [Related]
3. Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019.
Yamaya T; Hagiwara E; Baba T; Kitayama T; Murohashi K; Higa K; Sato Y; Otoshi R; Tabata E; Shintani R; Okabayashi H; Ikeda S; Niwa T; Nakazawa A; Oda T; Okuda R; Sekine A; Kitamura H; Komatsu S; Ogura T
Respir Investig; 2021 Sep; 59(5):596-601. PubMed ID: 33965361
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Krebs von den Lungen-6 and fibronectin with pulmonary fibrosis in coronavirus disease 2019.
Peng DH; Luo Y; Huang LJ; Liao FL; Liu YY; Tang P; Hu HN; Chen W
Clin Chim Acta; 2021 Jun; 517():48-53. PubMed ID: 33631198
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
6. Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II.
d'Alessandro M; Bergantini L; Cavallaro D; Gangi S; Cameli P; Conticini E; Siena Covid Unit ; Frediani B; Dotta F; Bargagli E
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206372
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of serum Krebs von den Lungen-6 levels in patients with coronavirus disease 2019.
Chen H; Qin R; Huang Z; Luo W; Zheng P; Huang H; Hu H; Wang H; Sun B
Cytokine; 2021 Dec; 148():155513. PubMed ID: 34507246
[TBL] [Abstract][Full Text] [Related]
8. Serum SP-A and KL-6 levels can predict the improvement and deterioration of patients with interstitial pneumonia with autoimmune features.
Wang J; Zheng P; Huang Z; Huang H; Xue M; Liao C; Sun B; Zhong N
BMC Pulm Med; 2020 Dec; 20(1):315. PubMed ID: 33267857
[TBL] [Abstract][Full Text] [Related]
9. Serum Krebs von den Lungen-6 for Predicting the Severity of COVID-19 Lung Injury: A Systematic Review and Meta-Analysis.
Pramana Witarto A; Samarta Witarto B; Er Putra AJ; Pramudito SL; Rosyid AN
Iran Biomed J; 2021 Nov; 25(6):381-9. PubMed ID: 34641641
[TBL] [Abstract][Full Text] [Related]
10. Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses.
Naderi N; Rahimzadeh M
Virology; 2022 Jan; 566():106-113. PubMed ID: 34896901
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
[TBL] [Abstract][Full Text] [Related]
12. Prognostic roles of KL-6 in disease severity and lung injury in COVID-19 patients: A longitudinal retrospective analysis.
Deng K; Fan Q; Yang Y; Deng X; He R; Tan Y; Lan Y; Deng X; Pan Y; Wang Y; Guan Y; Liu H; Chen F; Mo X; Tan X; Luo C; Wen X; Liu Y; Liu J; Zhang L; Tang X; Hu F; Li F
J Med Virol; 2021 Apr; 93(4):2505-2512. PubMed ID: 33433006
[TBL] [Abstract][Full Text] [Related]
13. Could KL-6 levels in COVID-19 help to predict lung disease?
Frix AN; Schoneveld L; Ladang A; Henket M; Duysinx B; Vaillant F; Misset B; Moutschen M; Louis R; Cavalier E; Guiot J
Respir Res; 2020 Nov; 21(1):309. PubMed ID: 33234132
[TBL] [Abstract][Full Text] [Related]
14. Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease.
Qin H; Xu XP; Zou J; Zhao XJ; Wu HW; Zha QF; Chen S; Kang Y; Jiang HD
Pulmonology; 2019; 25(3):143-148. PubMed ID: 30007895
[TBL] [Abstract][Full Text] [Related]
15. Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks.
Arnold DT; Donald C; Lyon M; Hamilton FW; Morley AJ; Attwood M; Dipper A; Barratt SL
PLoS One; 2021; 16(4):e0249607. PubMed ID: 33914762
[TBL] [Abstract][Full Text] [Related]
16. Peak value of serum KL-6 may be useful for predicting poor prognosis of severe COVID-19 patients.
Maruyama S; Nakamori Y; Nakano H; Tsuyumu K; Kanayama S; Iwamura H; Wada D; Yoshihara T; Saito F; Yoshiya K; Kuwagata Y
Eur J Med Res; 2022 May; 27(1):69. PubMed ID: 35590343
[TBL] [Abstract][Full Text] [Related]
17. Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients.
Xue M; Zhang T; Chen H; Zeng Y; Lin R; Zhen Y; Li N; Huang Z; Hu H; Zhou L; Wang H; Zhang XD; Sun B
Int J Biol Sci; 2021; 17(6):1565-1573. PubMed ID: 33907520
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of serum Krebs von den Lungen-6 (KL-6) levels in COVID-19 pneumonia.
Letellier A; Rolland-Debord C; Luque-Paz D; Milon A; Choinier P; Blin E; Halitim P; Bravais J; Lefèvre G; Parrot A; Piéroni L; Cadranel J
Respir Med Res; 2023 Nov; 84():101054. PubMed ID: 37897878
[TBL] [Abstract][Full Text] [Related]
19. Serum KL-6 level as a biomarker of interstitial lung disease in childhood connective tissue diseases: a pilot study.
Kilinc AA; Arslan A; Yildiz M; Kucur M; Adrovic A; Barut K; Sahin S; Cokugras H; Kasapcopur O
Rheumatol Int; 2020 Oct; 40(10):1701-1706. PubMed ID: 31784789
[TBL] [Abstract][Full Text] [Related]
20. Clinical Usefulness of Serum Krebs von den Lungen-6 for Detecting Chronic Aspiration in Children with Severe Motor and Intellectual Disabilities.
Wakamoto H; Sano N; Yano Y; Sakai S; Kikuchi T; Fukuda M; Morimoto T; Ishii E
J Pediatr; 2015 Nov; 167(5):1136-42. PubMed ID: 26382626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
